It is proposed that the effects of RJ and irisin on obesity‐induced metabolic disorders occur through common pathways, which include inducing thermogenesis through the browning of white adipose tissue, activation of brown adipose tissue, and increasing energy metabolism. The gene discussed is FNDC5; the disease is metabolic disease.